Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer

Takeyoshi Yamauchi, Masahiko Watanabe, Tetsuro Kubota, Hirotoshi Hasegawa, Yoshiyuki Ishii, Takashi Endo, Yasuo Kabeshima, Kyoko Yorozuya, Kentaro Yamamoto, Makio Mukai, Masaki Kitajima

研究成果: Article査読

79 被引用数 (Scopus)

抄録

PURPOSE: Epidemiologic studies indicate that the use of nonsteroidal anti-inflammatory drugs, which inhibit cyclooxygenase activity, reduce the risk of colorectal cancer. In addition, several studies demonstrate increased expression of cyclooxygenase-2 in human colorectal cancer tissues. However, the role of cyclooxygenase-2 expression in colorectal cancer has not yet been fully established. The aim of this study was to clarify the clinicopathologic significance of cyclooxygenase-2 expression in human colorectal cancer. METHODS: A total of 232 surgically resected colorectal cancer specimens were analyzed immunohistochemically with the use of a murine anti-human cyclooxygenase-2 monoclonal antibody. Cyclooxygenase-2 expression was then compared with clinicopathologic background and survival outcome. RESULTS: Cyclooxygenase-2 was expressed in the cytoplasm of the cancer cells but not in normal epithelium. Cyclooxygenase-2 expression was noted in 71.6 percent (166/232) of the cancer patients and correlated significantly with histologic type (P = 0.033), depth of invasion (P = 0.016), pathologic stage (P = 0.020), and metachronous liver metastasis (P = 0.001). Multivariate analysis for factors associated with metachronous liver metastasis showed that cyclooxygenase-2 expression was one of the independent risk factors, second only to lymph node metastasis. Patients with cyclooxygenase-2 expression showed a significantly poorer outcome compared with those without cyclooxygenase-2 expression (P = 0.002). CONCLUSION: Cyclooxygenase-2 expression in the primary lesion may be a useful marker for evaluating prognosis and liver metastasis in patients with colorectal cancer.

本文言語English
ページ(範囲)98-103
ページ数6
ジャーナルDiseases of the colon and rectum
45
1
DOI
出版ステータスPublished - 2002 1 29

ASJC Scopus subject areas

  • Gastroenterology

フィンガープリント 「Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル